Zobrazeno 1 - 10
of 689
pro vyhledávání: '"Robert G. Gish"'
Autor:
Mondher Toumi, Jack Wallace, Chari Cohen, Chris Marshall, Helen Kitchen, Jake Macey, Hannah Pegram, Ashley F. Slagle, Robert G. Gish, Qin Ning, Hiroshi Yatsuhashi, Markus Cornberg, Maurizia Brunetto, Florian van Bömmel, Qing Xie, Dee Lee, Noriyuki Habuka, Urbano Sbarigia, Maria Beumont-Mauviel, Angelina Villasis Keever, Yasushi Takahashi, Yiwei Lu, Ao Liu, Qiaoqiao Chen, Tetsuro Ito, Olaf Radunz, Anna Puggina, Gudrun Hilgard, Eric K.H. Chan, Su Wang
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background People with chronic hepatitis B (CHB) commonly experience social and self-stigma. This study sought to understand the impacts of CHB-related stigma and a functional cure on stigma. Methods Adults with CHB with a wide range of age
Externí odkaz:
https://doaj.org/article/847717b9ff4f4e0e964d47ea63825fd7
Publikováno v:
Gastroenterology & Hepatology; Oct2023, Vol. 19 Issue 10, p603-605, 3p
Autor:
Catherine Freeland, Vivek Sreepathi, Richard W. Hass, Jonathan M. Fenkel, Jessie Torgersen, Kenneth Rothstein, Chari Cohen, Robert G. Gish
Publikováno v:
Journal of Virus Eradication, Vol 9, Iss 4, Pp 100358- (2023)
Within the United States (US), 2.4 million individuals are living with chronic hepatitis B, but less than 20% are diagnosed. Isolated anti-hepatitis B core (iAHBc) antibodies indicate serology in an individual that is positive for anti-HBc antibodies
Externí odkaz:
https://doaj.org/article/d09d36a04f884fdabb7fa76fc4e82efb
Publikováno v:
JHEP Reports, Vol 5, Iss 10, Pp 100852- (2023)
Background & Aims: The vast majority of studies evaluating differences in on-treatment risks of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) have been conducted in Asia. Data on the course of CHB on antiviral therapy amon
Externí odkaz:
https://doaj.org/article/063bd14c8f33431ca0c4fa8514bbce46
Autor:
Nan Lin, Yongping Lin, Jianfeng Xu, Dan Liu, Diange Li, Hongyu Meng, Maxime A. Gallant, Naoto Kubota, Dhruvajyoti Roy, Jason S. Li, Emmanuel C. Gorospe, Morris Sherman, Robert G. Gish, Ghassan K. Abou‐Alfa, Mindie H. Nguyen, David J. Taggart, Richard A. Van Etten, Yujin Hoshida, Wei Li
Publikováno v:
Hepatology Communications, Vol 6, Iss 7, Pp 1753-1763 (2022)
Abstract The limited performance of guideline‐recommended abdominal ultrasound and serum alpha‐fetoprotein (AFP) highlights the urgent, unmet need for new biomarkers for more accurate detection of early hepatocellular carcinoma (HCC). To this end
Externí odkaz:
https://doaj.org/article/28c10d8ae2014899a358709c88f612fb
Autor:
Trang N.D. Pham, Duc H. Le, Diem V.B. Dao, Loc T.B. Phan, Thuy T.T. Pham, Toan B. Nguyen, Gary W. Mize, Robert G. Gish, William M. Lee, Amy Trang, Anh N. Le, Moon Chen, Jr., Hai T. Phan, Binh T. Nguyen, Hong K. Tang, Doan Y. Dao
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 30, Iss , Pp 100620- (2023)
Summary: Background: We conducted a community-based seroprevalence study using three HBV seromarkers (HBsAg, anti-HBs, anti-HBc) in Ho Chi Minh City (HCMC), Vietnam, to (1) determine the prevalence of HBV serologic profiles; (2) document factors asso
Externí odkaz:
https://doaj.org/article/d08b67344cd94359b1d7b4d45a3abcee
Autor:
Thanh V. Kim, Duc H. Le, Diem V.B. Dao, Trang Ngoc Doan Pham, Gary W. Mize, Loc T.B. Phan, Dan X. Nguyen, Thi-Thuy-Dung Ngo, Robert G. Gish, William M. Lee, Amy Trang, Anh N. Le, Moon Chen, Jr., Hai T. Phan, Binh T. Nguyen, Hong K. Tang, Doan Y Dao
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 27, Iss , Pp 100524- (2022)
Summary: Background: A baseline of hepatitis C virus (HCV) burden and other HCV epidemiological profiles is necessary for HCV micro-elimination in Ho Chi Minh City (HCMC), Viet Nam. This study aimed to determine HCV exposure and prevalence of HCV vir
Externí odkaz:
https://doaj.org/article/9e7d4d432b544ff6b9c1ca7f7f3874c2
Autor:
Katerina Roma, Robert G. Gish
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 4, Pp 556-557 (2023)
Externí odkaz:
https://doaj.org/article/a80ba2f2c0db41828982aee15326feaf
Autor:
Yanina Bogliotti, Mark Vander Roest, Aras N. Mattis, Robert G. Gish, Gary Peltz, Robin Anwyl, Salah Kivlighn, Eric R. Schuur
Publikováno v:
Cells, Vol 11, Iss 13, p 1998 (2022)
Liver disease is a leading cause of mortality worldwide, resulting in 1.3 million deaths annually. The vast majority of liver disease is caused by metabolic disease (i.e., NASH) and alcohol-induced hepatitis, and to a lesser extent by acute and chron
Externí odkaz:
https://doaj.org/article/c91ee481ad5a4ef09fbe50118203adfa
Publikováno v:
Clinics in Liver Disease. 27:17-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c373c13ed42b87ac5dd7513783df9af
https://doi.org/10.1016/j.cld.2022.08.001
https://doi.org/10.1016/j.cld.2022.08.001